Carthera

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$4.8M

Carthera is a medtech company that develops innovative ultrasound-based devices to treat brain disorders by temporarily opening the Blood-Brain Barrier, currently focusing on clinical trials for treating recurrent glioblastoma with their SonoCloud technology.

Total Funding

$4.8M

Headquarters

Paris, France

Founded

2010

Website

carthera.eu

Focus Areas

Medtech

Ultrasound Devices

Brain Disorders

Blood-Brain Barrier

Clinical Trials

Glioblastoma Treatment

Investors